Ketan Patel | |
|---|---|
 Patel in 2019 | |
| Born | Ketan Rajnibhai Patel |
| Alma mater |
|
| Occupation(s) | Pharmacist, businessman |
Ketan Rajnibhai Patel is an Indian pharmacist, innovator, and serves as the chairman & managing director of Troikaa Pharmaceuticals Ltd., a pharmaceutical company headquartered in Gujarat, India. [1]
Patel earned Gold Medals during both his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He received a Ph.D. in Pharmaceutical Technology, which he obtained from Dharamsinh Desai University, Gujarat. [2]
Patel established the "Rajnibhai.V. Patel Pharmlnnova Award" under the aegis of the Department of Science and Technology (India). [3] [4]
Details of his career are documented in the book titled 'THE INNOVATORS,' published by the Department of Science and Technology (India) Government of India. [5]
Patel held the position of chairman of the Board of Governors at NIPER, Ahmedabad [6] and also served as a member of the Board of Governors for Gujarat Technological University. [7] [8] He is also a member of the Academic Council at National Forensic Sciences University, Ahmadabad (Also known as Gujarat Forensic Sciences University). [9]
He also serves as a member of the Board of Directors at i-HUB, one of the biggest startup institutes established by the Government of Gujarat. [10]
Patel is the chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER), Gandhinagar. [11]
Patel is the primary inventor and patent holder of a painless diclofenac injection marketed under the brand name 'DYNAPAR-AQ' by Troikaa Pharmaceuticals Ltd. His innovation earned recognition from the Government of India’s Department of Science & Industrial Research, which honored him with the National Award in 2008. [12] [13]
In 2008, he invented a quick, powerful & long-lasting penetrating solution of Diclofenac designed for Topical administration known as “Dynapar QPS”, for which he was conferred with a National Award in 2015 from the Department of Science & Technology, Govt of India. [14]
In 2019, he introduced a solution for Vitamin B12 deficiency. NasoB12, the world's first globally approved nasal drug delivery system, utilizes Methylcobalamin, the biologically active form of Vitamin B12, to effectively address Vitamin B12 deficiency, which has high prevalence in India and developing nations. NASO B12 was honored with the "India Star Award" for outstanding packaging design. This award was provided by the Indian Institute of Packaging, an autonomous body operating under the aegis of the Ministry of Commerce and Industry, Government of India. [15] [16]
In 2023, Xykaa IM, world’s first 500mg Paracetamol/2ml injection was introduced by Ketan Patel and Milan Patel. This is a medicine for rapid control of high fever. It provides quick potent fever relief with 72% higher bio availability than oral Paracetamol. [17] [18]
